Manchester Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-49
Closed -$4K – 1148
2022
Q1
$4K Hold
49
– – ﹤0.01% 706
2021
Q4
$4K Buy
49
+12
+32% +$877 ﹤0.01% 734
2021
Q3
$2K Buy
+37
New +$2.62K ﹤0.01% 892
2015
Q1
– Sell
-207
Closed -$10K – 853
2014
Q4
$10K Hold
207
– – ﹤0.01% 972
2014
Q3
$12K Hold
207
– – ﹤0.01% 934
2014
Q2
$10K Hold
207
– – ﹤0.01% 945
2014
Q1
$9K Hold
207
– – ﹤0.01% 861
2013
Q4
$9K Hold
207
– – ﹤0.01% 804
2013
Q3
$9K Sell
207
-124
-37% -$5.19K ﹤0.01% 839
2013
Q2
$15K Buy
+331
New +$14.8K ﹤0.01% 787

Other funds holding THC

Manchester Capital Management's THC Position: Q2 2022 in Review

Manchester Capital Management sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 49 shares — an estimated $4K sold.

Manchester Capital Management first reported a position in THC in Q2 2013 and held it in 10 quarters. The position peaked at $15K in Q2 2013. 371 funds tracked by Wall St. Rank hold THC as of Q2 2022.

  • Manchester Capital Management reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
  • Manchester Capital Management sold 49 Tenet Healthcare shares in Q2 2022, an estimated $4K.
  • Manchester Capital Management first reported a position in Tenet Healthcare in Q2 2013 and held it in 10 quarters.
  • Manchester Capital Management's Tenet Healthcare position peaked at $15K in Q2 2013.
  • 371 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.

Based on Manchester Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.